Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Cancer Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04913922
What this trial is testing

Relatlimab With Nivolumab and 5-Azacytidine for the Treatment of AML

Who this might be right for
Acute Myeloid Leukemia
Ludwig-Maximilians - University of Munich 30
Testing effectiveness (Phase 2)WithdrawnNCT01854372
What this trial is testing

Rituximab-HyperCVAD (R-HCVAD) Alternating With Rituximab-Methotrexate-Cytarabine- (R-MC) in Newly Diagnosed Patients With Diffuse Large B-Cell Lymphoma With MYC-Rearrangement.

Who this might be right for
Newly Diagnosed Diffuse Large B-Cell LymphomaIntermediate (Burkitt-Like) Lymphoma
The University of Texas Health Science Center at San Antonio
Post-approval studies (Phase 4)Ended earlyNCT04289805
What this trial is testing

Controlled Ovarian Stimulation in Newly Diagnosed Breast Cancer PatiEnts (fAMHOPE)

Who this might be right for
Breast Neoplasm Malignant Female
Erasme University Hospital 96
Not applicableUnknownNCT03419494
What this trial is testing

Comparison of Liposomal Doxorubicin and Daunorubicin-containing VDCLD Regimen in the Treatment of Adult ALL Patients

Who this might be right for
Adult Acute Lymphoblastic Leukemia
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT00089167
What this trial is testing

Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00093600
What this trial is testing

PKC412, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
Novartis Pharmaceuticals 69
Not applicableUnknownNCT04942756
What this trial is testing

GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Glucose Monitoring (CGM) by Using FreeStyle Libre 2 (FSL2) for Preventing Hyperglycemia/Hypoglycemia Crisis in Advanced Oncological Patients.

Who this might be right for
Palliative CareDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1+6 more
Antea Foundation 118
Testing effectiveness (Phase 2)Looking for participantsNCT07228273
What this trial is testing

Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
OHSU Knight Cancer Institute 102
Testing effectiveness (Phase 2)WithdrawnNCT03065712
What this trial is testing

Test - Retest Reproducibility of 18F Fluoroestradiol (FES) PET

Who this might be right for
Breast Cancer
University of Texas Southwestern Medical Center
Testing effectiveness (Phase 2)Study completedNCT03236792
What this trial is testing

Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis

Who this might be right for
AL Amyloidosis
Icahn School of Medicine at Mount Sinai 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07070934
What this trial is testing

CAR-T vs. Auto-SCT: Which Works Better for New Myeloma Patients?

Who this might be right for
Multiple MyelomaNewly Diagnosed
Xuzhou Medical University 60
Large-scale testing (Phase 3)Active Not RecruitingNCT04799275
What this trial is testing

Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma

Who this might be right for
Ann Arbor Stage III Diffuse Large B-Cell LymphomaAnn Arbor Stage IIX (Bulky) Diffuse Large B-Cell LymphomaAnn Arbor Stage IV Diffuse Large B-Cell Lymphoma+18 more
National Cancer Institute (NCI) 422
Not applicableStudy completedNCT02289014
What this trial is testing

Web-based Stress Management for Newly Diagnosed Cancer Patients (STREAM-1)

Who this might be right for
Psychological DistressCancer
University Hospital, Basel, Switzerland 129
Large-scale testing (Phase 3)Study completedNCT03901963
What this trial is testing

Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Participants With Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 200
Large-scale testing (Phase 3)Study completedNCT01460693
What this trial is testing

Comparison of Imatinib Versus Dasatinib in Patients With Newly-diagnosed Chronic Phase Chronic Myeloid Leukaemia

Who this might be right for
Myeloid Leukemia, Chronic, Chronic Phase
Newcastle University 814
Large-scale testing (Phase 3)Looking for participantsNCT05804370
What this trial is testing

Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)

Who this might be right for
Ovarian Cancer
NX Development Corp 170
Large-scale testing (Phase 3)Ended earlyNCT01650805
What this trial is testing

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

Who this might be right for
Chronic Myeloid Leukemia
Ariad Pharmaceuticals 307
Testing effectiveness (Phase 2)Active Not RecruitingNCT04231851
What this trial is testing

CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia

Who this might be right for
Acute Myelogenous Leukemia (AML) Due to TherapyAcute Myeloid Leukemia With Myelodysplasia-Related Changes
University of California, Irvine 30
Not applicableLooking for participantsNCT03526822
What this trial is testing

Prospective Cohort of Patients With Newly Diagnosed Glioblastoma: Analysis of MMP2 and MMP9 Expression and Correlation to Neuro-imaging Features.

Who this might be right for
Brain Tumor
Assistance Publique Hopitaux De Marseille 100
Early research (Phase 1)Study completedNCT00989651
What this trial is testing

Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CarcinomaFallopian Tube CarcinosarcomaFallopian Tube Clear Cell Adenocarcinoma+35 more
National Cancer Institute (NCI) 431
Next Page